Nyrada (ASX:NYR) Inc's James Bonnar speaks with Proactive at the ASX Small and Mid Cap Conference. Nyrada is a preclinical stage, drug discovery, and development company, specialising in novel small molecule drugs to treat cardiovascular and neurological diseases. It has two main programs - a cholesterol-lowering drug and a drug to treat brain injury.
Nyrada Inc with Proactive at the ASX Small and Mid Cap Conference
Quick facts: Nyrada
Price: 0.255 AUD
Market Cap: $39.78 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...FOR OUR FULL DISCLAIMER CLICK HERE